ScholarIQanswers from OpenAlex

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients

PaperCitations, authors & open-access status

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients have?

ScholarIQcitation count

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients has 114 citations in the OpenAlex counts ScholarIQ stores.

When was Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients published?

ScholarIQyear

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients has 2001 year in the ScholarIQ index.

What is the open-access status of Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients?

ScholarIQoa status

Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients has closed oa status in the ScholarIQ index.

What is the DOI of Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients?

ScholarIQdoi

The DOI for Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients is on the source record.

What is the PMID of Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients?

ScholarIQpmid

The PMID for Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients is on the source record.

What is the OpenAlex record for Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients?

ScholarIQopenalex

The OpenAlex for Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial